We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+21.94%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$34.9B
AUM Growth
+$6.68B
(+24%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
5.58%
Top 10 Holdings %
Top 10 Hldgs %
7.42%
Holding
3,971
New
955
Increased
1,167
Reduced
1,145
Closed
694
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Consumer Discretionary | 13.39% |
| 3 | Financials | 9.05% |
| 4 | Healthcare | 8.71% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
CALL
Fastly Inc
FSLY
$3.66B
| $5.29M | 0.02% |
60,500
-96,100
| -61% | -$8.47M |
|
|
MRSN
902
DELISTED
Mersana Therapeutics
MRSN
| $5.28M | 0.02% |
7,933
+1,222
| +18% | +$680K |
|
903
CALL
Coca-Cola
KO
$375B
| $5.28M | 0.02% |
96,200
-84,400
| -47% | -$4.36M |
|
904
PBF Energy
PBF
$7.31B
| $5.28M | 0.02% |
742,889
-403,059
| -35% | -$2.63M |
|
905
Antero Midstream
AM
$10.1B
| $5.27M | 0.02% |
+684,013
| New | +$4.64M |
|
|
WBA
906
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $5.25M | 0.02% |
131,600
-333,900
| -72% | -$12.9M |
|
907
Kinross Gold
KGC
$32.8B
| $5.22M | 0.02% |
+711,204
| New | +$5.67M |
|
908
Oaktree Specialty Lending
OCSL
$1.14B
| $5.22M | 0.02% |
312,301
+60,834
| +24% | +$945K |
|
|
BBBY
909
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
| $5.21M | 0.02% |
293,500
| – | – |
|
910
Cartesian Therapeutics
RNAC
$268M
| $5.2M | 0.01% |
57,232
+31,080
| +119% | +$2.7M |
|
911
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $5.2M | 0.01% |
+59,508
| New | +$5.1M |
|
912
Veritone
VERI
$122M
| $5.18M | 0.01% |
182,233
+80,892
| +80% | +$1.4M |
|
913
PUT
CVS Health
CVS
$122B
| $5.16M | 0.01% |
75,600
-42,700
| -36% | -$2.78M |
|
|
DCH
914
Dauch Corp
DCH
$1.51B
| $5.13M | 0.01% |
+615,306
| New | +$4.63M |
|
|
XENT
915
DELISTED
Intersect ENT, Inc
XENT
| $5.11M | 0.01% |
223,221
+59,814
| +37% | +$1.14M |
|
916
Roper Technologies
ROP
$39.8B
| $5.1M | 0.01% |
11,838
-32,137
| -73% | -$13.2M |
|
917
Chemed
CHE
$7.22B
| $5.1M | 0.01% |
9,576
-19,018
| -67% | -$9.34M |
|
|
TBHC
918
DELISTED
The Brand House Collective
TBHC
| $5.1M | 0.01% |
285,042
+81,512
| +40% | +$1.11M |
|
919
CALL
Salesforce
CRM
$158B
| $5.1M | 0.01% |
22,900
-42,200
| -65% | -$10.3M |
|
920
CALL
Kimberly-Clark
KMB
$36.5B
| $5.08M | 0.01% |
37,700
+34,800
| +1,200% | +$4.87M |
|
|
GTHX
921
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $5.08M | 0.01% |
282,475
+119,165
| +73% | +$1.78M |
|
922
CALL
lululemon athletica
LULU
$14.6B
| $5.08M | 0.01% |
14,600
-16,600
| -53% | -$5.76M |
|
923
Graco
GGG
$13.5B
| $5.08M | 0.01% |
70,168
-30,337
| -30% | -$2.03M |
|
|
SFIX
924
CALL
Stitch Fix
SFIX
$560M
| $5.07M | 0.01% |
86,300
+30,900
| +56% | +$1.32M |
|
|
KSU
925
DELISTED
Kansas City Southern
KSU
| $5.07M | 0.01% |
+24,823
| New | +$4.66M |
|
Similar funds
VAM
Two Sigma Investments's Q4 2020 Portfolio in Review
As of Q4 2020, Two Sigma Investments held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
Two Sigma Investments deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- Two Sigma Investments's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- Two Sigma Investments added most to NVIDIA in Q4 2020, an estimated $257M increase.
- Two Sigma Investments's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- Two Sigma Investments fully exited Pfizer in Q4 2020, selling an estimated $252M.
- Two Sigma Investments's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- Two Sigma Investments opened 955 new positions and closed 694 in Q4 2020.
- Two Sigma Investments's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.